ENSG
NASDAQ · Health Care
Ensign Group Inc/The
$203.89
+0.97 (+0.48%)
Financial Highlights (FY 2026)
Revenue
4.94B
Net Income
335.71M
Gross Margin
21.1%
Profit Margin
6.8%
Rev Growth
+18.7%
D/E Ratio
0.06
Revenue & Net Income
Margin Trends
| FY 2026 | FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|---|
| Gross Margin | 21.1% | 21.1% | 41.2% | 41.2% |
| Operating Margin | 8.4% | 7.6% | 11.7% | 14.0% |
| Profit Margin | 6.8% | 6.5% | 10.8% | 11.0% |
Income Statement
| FY 2026 | FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|---|
| Revenue | 4.94B | 4.16B | 4.21B | 4.15B |
| Gross Profit | 1.04B | 876.39M | 1.73B | 1.71B |
| Operating Income | 415.15M | 314.83M | 490.49M | 578.58M |
| Net Income | 335.71M | 254.58M | 452.95M | 453.91M |
| Gross Margin | 21.1% | 21.1% | 41.2% | 41.2% |
| Operating Margin | 8.4% | 7.6% | 11.7% | 14.0% |
| Profit Margin | 6.8% | 6.5% | 10.8% | 11.0% |
| Rev Growth | +18.7% | +18.7% | +1.5% | -7.5% |
Balance Sheet
| FY 2026 | FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|---|
| Total Debt | 355.48M | 355.48M | 3.37B | 3.51B |
| Total Equity | 5.60B | 5.60B | 4.63B | 4.21B |
| D/E Ratio | 0.06 | 0.06 | 0.73 | 0.83 |
Cash Flow
| FY 2026 | FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|---|
| EBITDA | 530.38M | 424.55M | 812.11M | 863.45M |
| Free Cash Flow | — | — | 544.25M | 422.07M |